PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER

被引：0
|
作者：
Gulec, U. Kucukgoz [1 ]
Bagir, E. [2 ]
Paydas, S. [3 ]
Seydaoglu, G. [4 ]
Guzel, A. B. [1 ]
Vardar, M. A. [1 ]
机构：
[1] Cukurova Univ, Sch Med Obstet & Gynecol, Adana, Turkey
[2] Cukurova Univ, Sch Med, Pathol, Adana, Turkey
[3] Cukurova Univ, Sch Med, Med Oncol, Adana, Turkey
[4] Cukurova Univ, Sch Med, Biostat, Adana, Turkey
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-135
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [31] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer
    Maureen L. Drakes
    Swati Mehrotra
    Monica Aldulescu
    Ronald K. Potkul
    Yueying Liu
    Anne Grisoli
    Cara Joyce
    Timothy E. O’Brien
    M. Sharon Stack
    Patrick J. Stiff
    [J]. Journal of Ovarian Research, 11
  • [32] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Lathika, Aryakrishna S.
    Lakshmi, S.
    Ramdas, Preethi T.
    Kumar, Aswin
    Mathews, Susan
    Joseph, John
    Mathew, Aleyamma
    James, Francis V.
    [J]. INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (04)
  • [33] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand-1 (PD-L1) in ovarian cancer
    Drakes, Maureen L.
    Mehrotra, Swati
    Aldulescu, Monica
    Potkul, Ronald K.
    Liu, Yueying
    Grisoli, Anne
    Joyce, Cara
    O'Brien, Timothy E.
    Stack, M. Sharon
    Stiff, Patrick J.
    [J]. JOURNAL OF OVARIAN RESEARCH, 2018, 11
  • [34] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Aryakrishna S. Lathika
    S. Lakshmi
    Preethi T. Ramdas
    Aswin Kumar
    Susan Mathews
    John Joseph
    Aleyamma Mathew
    Francis V. James
    [J]. Indian Journal of Gynecologic Oncology, 2021, 19
  • [35] Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer
    Nunez Abad, Martin
    Calabuig-Farinas, Silvia
    Lobo de Mena, Miriam
    Torres-Martinez, Susana
    Garcia Gonzalez, Clara
    Garcia Garcia, Jose Angel
    Iranzo Gonzalez-Cruz, Vega
    Camps Herrero, Carlos
    [J]. CANCERS, 2022, 14 (02)
  • [36] Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction
    Wang, Yu
    Huang, Kun
    Gao, Yali
    Yuan, Dandan
    Ling, Lin
    Liu, Jieqing
    Wu, Sihai
    Chen, Roufen
    Li, He
    Xiong, Yizu
    Liu, Han
    Ma, Junjie
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 229
  • [37] Targeting Programmed Cell Death-1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy
    Constantinidou, Anastasia
    Alifieris, Constantinos
    Trafalis, Dimitrios T.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2019, 194 : 84 - 106
  • [38] The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor
    Brinch, Charlotte Margareta
    Hogdall, Estrid
    Junker, Niels
    Moeller, Holger Jon
    Sandfeld-Paulsen, Birgitte
    de Heer, Pieter
    Penninga, Luit
    Rossen, Philip Blach
    Krarup-Hansen, Anders
    Aggerholm-Pedersen, Ninna
    [J]. CANCERS, 2022, 14 (23)
  • [39] In Reply: Programmed Death-Ligand 1 (PD-L1) Immunohistochemistry Calibration
    Sompuram, Seshi R.
    Torlakovic, Emina E.
    t' Hart, Nils A.
    Vani, Kodela
    Bogen, Steven A.
    [J]. MODERN PATHOLOGY, 2023, 36 (02)
  • [40] Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer
    Jove, Maria
    Vilarino, Noelia
    Nadal, Ernest
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S364 - S368
12345